Markulan, L. Y., and L. M. Makarevych. 2022. “Pembrolizumab As an Immunotherapy Drug in the Treatment of a patient with recurrent (unresectable) Cancer of the Lower Lip”. General Surgery, no. 2 (December):75-82. https://doi.org/10.30978/GS-2022-2-75.